Skip to content
Politically.com Search all
Menu

2026 · 3rd Quarter (July 1 - Sep 30)

BROAD INSTITUTE INC.

Filed by BROAD INSTITUTE INC..

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-11-04 06:26:19 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2026
Income
Not reported
Expenses
$60,000.00
Filing UUID
fd6d8d71-b642-495a-9bff-e908152e3900
Termination date
Not reported

Expense method: A

Literal source text

Lobbying issues and bill citations

BUD · Budget/Appropriations

- General education about biomedical research and support for scientific funding. Transparency of federal funding for medical research dollars, including indirect costs. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. Support for the NIH All of Us Program. FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R.9260). - Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495).

Literal federal measure citations: H.R.9260, H.R.8800, S.4784, H.R.9495

SCI · Science/Technology

- General education about biomedical research and support for scientific funding. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Federal policies related to Office of Management and Budget (OMB) Uniform Guidance and their implications for federally funded biomedical research and research institutions. - Federal science and technology policy, including Office of Science and Technology Policy (OSTP) priorities related to the future of federally supported research, scientific institutions, and national research capabilities. - Federal policies and investments related to data infrastructure and artificial intelligence for biomedical research, including standards for secure and scalable data ecosystems.

MED · Medical/Disease Research/Clinical Labs

- General education about biomedical research and support for scientific funding. - Policies to advance AI supported long-term, population-scale health studies and accelerate translation of research findings to treatments. - Education and awareness regarding genetic medicines for rare and ultra-rare diseases.

DEF · Defense

- Federal funding for research and policy issues related to biomarkers and stress biology, including potential applications in defense and human performance. FY2027 National Defense Authorization Act (H.R.8800/S.4784) and FY2027 Department of Defense Appropriations Act (H.R.9495). - Education and discussion regarding Broad Institute capabilities and technologies relevant to national biological intelligence, biosurveillance, and reconnaissance (ISR). - General education regarding Broad Institutes research capabilities and areas of potential relevance to Defense Advanced Research Projects Agency (DARPA) programs and priorities.

Literal federal measure citations: H.R.8800, S.4784, H.R.9495

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.